Precigen (PGEN) Net Margin Growth (1y) (2013 - 2026)
Powered by 
Analysis
Precigen (PGEN) Net Margin Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 603.00 |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 2.25 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 13,865.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 6,876.00 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -67,094.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -2.38 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 314,889.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -3,345.00 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 371.00 |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 314,889.00 |
| Mar 31, 2026 | 400,415.00 |
| Dec 31, 2025 | 114,288.00 |
| Sep 30, 2025 | -861,824.00 |
| Jun 30, 2025 | 508,734.00 |
| Mar 31, 2025 | -180,933.00 |
| Dec 31, 2024 | 103,413.00 |
| Sep 30, 2024 | -108,059.00 |
| Jun 30, 2024 | -704,981.00 |
| Mar 31, 2024 | -100,072.00 |
| Dec 31, 2023 | -143,400.00 |
| Sep 30, 2023 | -195,800.00 |
| Jun 30, 2023 | -54,411.00 |
| Mar 31, 2023 | -87,901.00 |
| Dec 31, 2022 | -57,832.00 |
| Sep 30, 2022 | 141,555.00 |
| Jun 30, 2022 | -8,025.00 |
| Mar 31, 2022 | -27,854.00 |
| Dec 31, 2021 | -46,404.00 |
| Sep 30, 2021 | -76,789.00 |